The National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) has been offered annually since 2004 (previously known as the Commercialization Assistance Program), and is designed to help some of the agencyâs most promising small life science and healthcare Phase II awardees develop their commercial businesses and transition their SBIR/STTR-funded technologies into the marketplace. Applicants are selected via a competitive process for a limited number of slots in the program. Funded by NIH and managed through a contract, the CAP provides selected participants with individualized assistance toward accomplishing key commercialization goals. This is achieved through individual mentoring and consulting sessions, training workshops, access to domain experts, and focus on outcomes that will enhance the commercialization profile and readiness of participating awardees.
US Code:
15 USC 638
Name of Law: Small Business Act
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.